• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Sunday 07/22/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Vitality Biopharma

  • 11:15 AM

    THC prodrugs including VBX-100 designed to deliver cannabinoids for targeted therapeutic effects without psychoactivity LOS ANGELES, March 28, 2018 (GLOBE NEWSWIRE) — Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced the filing of its cannabosides intellectual property (Publ. No. WO2017053574 A1) in all major pharmaceutical markets worldwide. After initial submission through the Patent Cooperation

    Read more
  • 11:42 AM

    Approval of cannaboside pharmaceutical research included review by FDA and California Research Advisory Panel LOS ANGELES, CA– VBIO, (Marketwired – Dec 21, 2016) – Vitality Biopharma, Inc. (OTCQB: VBIO) (“Vitality Biopharma,” “Vitality,” or the “Company”), a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced that it has received approval from both the U.S. Drug Enforcement Agency (DEA) and the State of

    Read more
  • 3:43 PM

    Once concluded, IP protection extends to 2035 or longer in USA and all major markets worldwide LOS ANGELES, CA–VBIO, (Marketwired – Nov 9, 2016) – Vitality Biopharma, Inc. (OTCQB: VBIO) (“Vitality” or the “Company”), a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced the filing of an international PCT patent application, a milestone in its development of a platform of cannabinoid

    Read more
  • 1:54 PM

    LAKEWOOD, Colo., June 11, 2015 /CNW/ — Pershing Gold Corporation (OTCQB:PGLC) (“Pershing Gold” or the “Company”), an emerging Nevada gold producer, today announced that it has appointed Alan Branham (“Branham”) and Ed Karr (“Karr”) to its Board of Directors. Mr. Branham has more than 30 years of exploration and mine development experience. This has produced several gold discoveries totaling over 10 million ounces of gold. He is a Certified Professional Geologist with the American Institute of Professional Geologists. He has a B.S. in Geology from Stanford University and a M.Sc. In

    Read more
Public Wire Banner